Enhanced Intradermal Delivery of Nanosuspensions of Antifilariasis Drugs Using Dissolving Microneedles: A Proof of Concept Study
暂无分享,去创建一个
Ryan F. Donnelly | Maelíosa T. C. McCrudden | M. McCrudden | R. Donnelly | A. Permana | Andi Dian Permana
[1] Ryan F. Donnelly,et al. Microneedle-mediated Transdermal and Intradermal Drug Delivery , 2012 .
[2] Ming Kong,et al. Enhanced transdermal lymphatic delivery of doxorubicin via hyaluronic acid based transfersomes/microneedle complex for tumor metastasis therapy. , 2019, International journal of biological macromolecules.
[3] F. Ahmad,et al. Nanopharmaceuticals to target antifilarials: a comprehensive review , 2013, Expert opinion on drug delivery.
[4] Viness Pillay,et al. Current advances in the fabrication of microneedles for transdermal delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[5] Z. Zhang,et al. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] R. Tyagi,et al. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1. , 2016, International journal of pharmaceutics.
[7] Wei Sun,et al. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] Mark G. Allen,et al. Polymer Microneedles for Controlled-Release Drug Delivery , 2006, Pharmaceutical Research.
[9] A. Hoerauf. Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis , 2008, Current opinion in infectious diseases.
[10] Yvonne Perrie,et al. Formulation and manufacturing of lymphatic targeting liposomes using microfluidics. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[11] G. I. Taylor,et al. The lymphatics of the skin filled by a dermal backflow: an observation in a scarred cadaver leg. , 2007, Lymphology.
[12] Ryan F. Donnelly,et al. Hydrogel-Forming Microneedle Arrays Can Be Effectively Inserted in Skin by Self-Application: A Pilot Study Centred on Pharmacist Intervention and a Patient Information Leaflet , 2014, Pharmaceutical Research.
[13] Shaofei Xie,et al. DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles , 2010, The AAPS Journal.
[14] B. Hendriks,et al. Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment. , 2019, Nanomedicine : nanotechnology, biology, and medicine.
[15] Indrajit Ghosh,et al. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[16] S. P. Moulik,et al. Physicochemistry of Interaction of Polyvinylpyrrolidone (PVP) with Sodium Dodecyl Sulfate (SDS) in Salt Solution , 2013 .
[17] Barrett E. Rabinow,et al. Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.
[18] Maelíosa T. C. McCrudden,et al. Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[19] Maelíosa T. C. McCrudden,et al. In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[20] H. McCarthy,et al. Intradermal Delivery of a Near-Infrared Photosensitizer Using Dissolving Microneedle Arrays. , 2018, Journal of pharmaceutical sciences.
[21] Bao-de Shen,et al. Formulation of dried lignans nanosuspension with high redispersibility to enhance stability, dissolution, and oral bioavailability. , 2016, Chinese journal of natural medicines.
[22] K. Tarnow,et al. Intradermal injections: traditional bevel up versus bevel down. , 2004, Applied nursing research : ANR.
[23] M. Kron,et al. In Vitro Activity of Geldanamycin Derivatives against Schistosoma japonicum and Brugia malayi , 2010, Journal of parasitology research.
[24] Global programme to eliminate lymphatic filariasis: progress report, 2011. , 2012, Releve epidemiologique hebdomadaire.
[25] E. Ottesen. Global programme to eliminate lymphatic filariasis. , 2009, Releve epidemiologique hebdomadaire.
[26] Jayanth Panyam,et al. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[27] Christopher J. H. Porter,et al. From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity , 2015, Nature Reviews Drug Discovery.
[28] Yong Zhang,et al. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel , 2010, Comput. Methods Programs Biomed..
[29] Eneko Larrañeta,et al. Novel nanosuspension‐based dissolving microneedle arrays for transdermal delivery of a hydrophobic drug , 2018, Journal of interdisciplinary nanomedicine.
[30] P. Vavia,et al. Fabrication of isradipine nanosuspension by anti-solvent microprecipitation–high-pressure homogenization method for enhancing dissolution rate and oral bioavailability , 2012, Drug Delivery and Translational Research.
[31] C. Hascicek,et al. Design of vitamin E d-α-Tocopheryl Polyethylene Glycol 1000 Succinate-Emulsified Poly (D,L–Lactide–co-Glycolide) Nanoparticles: Influence of Duration of Ultrasonication Energy , 2011, Journal of Young Pharmacists.
[32] M. K. Chourasia,et al. Subcutaneously Administered Ultrafine PLGA Nanoparticles Containing Doxycycline Hydrochloride Target Lymphatic Filarial Parasites. , 2016, Molecular pharmaceutics.
[33] Timo Laaksonen,et al. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. , 2011, International journal of pharmaceutics.
[34] Ahmed Abdelbary,et al. Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration , 2015, International journal of nanomedicine.
[35] Eric A Ottesen,et al. Lymphatic filariasis: Treatment, control and elimination. , 2006, Advances in parasitology.
[36] B. Krishnamoorthy,et al. Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation , 2014, Expert opinion on drug delivery.
[37] C. Stoops,et al. Laboratory and Field Testing of Bednet Traps for Mosquito (Diptera: Culicidae) Sampling in West Java, Indonesia , 2010 .
[38] A. Hoerauf,et al. Doxycycline as a novel strategy against bancroftian filariasis—depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production , 2003, Medical Microbiology and Immunology.
[39] K. Ramaiah,et al. Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy , 2006 .
[40] Ryan F. Donnelly,et al. A proposed model membrane and test method for microneedle insertion studies , 2014, International journal of pharmaceutics.
[41] M. J. Santander-Ortega,et al. Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size. , 2016, International journal of pharmaceutics.
[42] P. Costa,et al. Modeling and comparison of dissolution profiles. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[43] R. Tan,et al. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[44] Emad B. Basalious,et al. Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: Simultaneous portal blood absorption and lymphatic delivery. , 2015, International journal of pharmaceutics.
[45] Gajanand Sharma,et al. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s). , 2017, International journal of pharmaceutics.
[46] R. Tan,et al. Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation. , 2009, International journal of pharmaceutics.
[47] Wei Chen,et al. Improved polyvinylpyrrolidone microneedle arrays with non-stoichiometric cyclodextrin. , 2014, Journal of materials chemistry. B.
[48] M. Raval,et al. Design and development of solid nanoparticulate dosage forms of telmisartan for bioavailability enhancement by integration of experimental design and principal component analysis , 2014 .
[49] W. Shujun,et al. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting. , 2014, International journal of pharmaceutics.
[50] Michel Cormier,et al. Microneedle-based vaccines. , 2009, Current topics in microbiology and immunology.
[51] B. F. Ardelli,et al. Brugia malayi: in vitro effects of ivermectin and moxidectin on adults and microfilariae. , 2010, Experimental parasitology.
[52] Ryan F. Donnelly,et al. Design, Optimization and Characterisation of Polymeric Microneedle Arrays Prepared by a Novel Laser-Based Micromoulding Technique , 2010, Pharmaceutical Research.
[53] Wei Wu,et al. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization. , 2012, International journal of pharmaceutics.
[54] R. Knight,et al. Lymphatic filariasis , 2020, Definitions.
[55] D. Jamison,et al. Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy -- Disease Control Priorities in Developing Countries , 2006 .
[56] Ryan F. Donnelly,et al. Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[57] A. Collier,et al. Long-Acting Profile of 4 Drugs in 1 Anti-HIV Nanosuspension in Nonhuman Primates for 5 Weeks After a Single Subcutaneous Injection. , 2018, Journal of pharmaceutical sciences.